These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 12665661)
1. Advanced glycoxidation. A new risk factor for cardiovascular disease? Peppa M; Uribarri J; Vlassara H Cardiovasc Toxicol; 2002; 2(4):275-87. PubMed ID: 12665661 [TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products and cardiovascular disease. Peppa M; Raptis SA Curr Diabetes Rev; 2008 May; 4(2):92-100. PubMed ID: 18473756 [TBL] [Abstract][Full Text] [Related]
3. The role of advanced glycation end products in the development of atherosclerosis. Peppa M; Uribarri J; Vlassara H Curr Diab Rep; 2004 Feb; 4(1):31-6. PubMed ID: 14764277 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease. Prasad K; Tiwari S Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648 [TBL] [Abstract][Full Text] [Related]
5. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions. Neviere R; Yu Y; Wang L; Tessier F; Boulanger E Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623 [TBL] [Abstract][Full Text] [Related]
6. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515 [TBL] [Abstract][Full Text] [Related]
8. Oxidation, glycation and glycoxidation-The vicious cycle and lung cancer. Ahmad S; Khan MY; Rafi Z; Khan H; Siddiqui Z; Rehman S; Shahab U; Khan MS; Saeed M; Alouffi S; Khan MS Semin Cancer Biol; 2018 Apr; 49():29-36. PubMed ID: 29055529 [TBL] [Abstract][Full Text] [Related]
9. Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster. Tsakiri EN; Iliaki KK; Höhn A; Grimm S; Papassideri IS; Grune T; Trougakos IP Free Radic Biol Med; 2013 Dec; 65():1155-1163. PubMed ID: 23999505 [TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs. Deluyker D; Evens L; Bito V Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551 [TBL] [Abstract][Full Text] [Related]
11. Advanced Glycation End Products and Their Involvement in Cardiovascular Disease. Yubero-Serrano EM; Pérez-Martínez P Angiology; 2020 Sep; 71(8):698-700. PubMed ID: 32242451 [No Abstract] [Full Text] [Related]
12. Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes. Planas A; Simó-Servat O; Hernández C; Simó R Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682915 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease. Yamagishi S; Fukami K; Matsui T Int J Cardiol; 2015 Apr; 185():263-8. PubMed ID: 25814214 [TBL] [Abstract][Full Text] [Related]
14. Assessment of protein glycoxidation in ventricular tissues. Li SY; Ren J Methods Mol Med; 2007; 139():313-28. PubMed ID: 18287682 [TBL] [Abstract][Full Text] [Related]
15. Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression. Lin JA; Wu CH; Lu CC; Hsia SM; Yen GC Mol Nutr Food Res; 2016 Aug; 60(8):1850-64. PubMed ID: 26774083 [TBL] [Abstract][Full Text] [Related]
16. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. Miyata T; Inagi R; Asahi K; Yamada Y; Horie K; Sakai H; Uchida K; Kurokawa K FEBS Lett; 1998 Oct; 437(1-2):24-8. PubMed ID: 9804165 [TBL] [Abstract][Full Text] [Related]
17. Glycoxidation and inflammation in chronic haemodialysis patients. Kalousová M; Sulková S; Fialová L; Soukupová J; Malbohan IM; Spacek P; Braun M; Mikulíková L; Fortová M; Horejsí M; Tesar V; Zima T Nephrol Dial Transplant; 2003 Dec; 18(12):2577-81. PubMed ID: 14605280 [TBL] [Abstract][Full Text] [Related]
18. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes. Yamagishi S; Nakamura N; Suematsu M; Kaseda K; Matsui T Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S32-40. PubMed ID: 26605646 [TBL] [Abstract][Full Text] [Related]
19. Lipoxidation in cardiovascular diseases. Gianazza E; Brioschi M; Fernandez AM; Banfi C Redox Biol; 2019 May; 23():101119. PubMed ID: 30833142 [TBL] [Abstract][Full Text] [Related]
20. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Miyata T; Maeda K; Kurokawa K; van Ypersele de Strihou C Nephrol Dial Transplant; 1997 Feb; 12(2):255-8. PubMed ID: 9132640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]